Pre-release allocation now open — 45% pricing active
Survodutide vial — front view

Specialty / Advanced

Survodutide

Research Compound

For research use only

Price · Single vial (AUD)

$299

$164

AUD

Limited research allocation

Pre-release pricing applied automatically at checkout

  • AU-based fulfilment
  • Discreet dispatch
  • Tracking provided
  • Secure checkout

Crypto settlement available at checkout.

Research Information

Compound profile

Neutral, scientific reference information provided for laboratory research contexts only.

Short Description

A dual GLP-1 and glucagon receptor agonist peptide studied in preclinical research.

Research Overview

Investigated in in vitro and preclinical research for dual incretin–glucagon receptor interactions.

Mechanism of Interest

Studied for binding at the GLP-1 and glucagon class B G-protein-coupled receptors and downstream cAMP signalling.

Key Research Areas

  • Dual receptor binding studies
  • Comparative analogue pharmacology
  • In vitro signalling assays
  • Preclinical pharmacokinetic research

Compliance Notice

For research use only. Not for human consumption. This product is not intended to diagnose, treat, cure, or prevent any disease.

Complete Your Research Set

Build a coordinated research set

Base Selection

Already selected

Common Research Pairing

Pre-selected

Extended Research Set

Optional

Selected Total

$234 AUD

For research use only. Items listed at standard AUD pricing — base product pricing is unchanged. Adjust the selection to suit your laboratory requirements.

Orders processed 24–48h
AU shipping
Discreet packaging
Tracking provided

Research Use Only. This product is supplied for laboratory research purposes only. Not intended for human or animal consumption, medical use, diagnostic use, therapeutic use, or performance enhancement.

Survodutide

$164 AUD